Search
Ginkgo biloba
An ornamental tree & the oldest species of tree. Medicinal use has been traced back to the Chinese Materia Medica from 2800 BC. The German physician Engelbert Kaempfer was the 1st European to catalog Ginkgo in the late 17th century. It was brought to the US in 1784. Ginkgo is the most resistant of all trees to infection & pollution.
Uses: Current uses:
1) symptomatic treatment of cognitive impairment* due to organic brain disease
a) Alzheimer's disease
- no benefit in prevention of Alzheimer's disease [13]
b) multi-infarct dementia
c) prevention of cognitive decline post ischemic stroke [17]
2) peripheral arterial disease*
3) headache
4) vertigo
5) asthma
6) tinnitus
7) macular degeneration [12]
8) no memory benefit for healthy elderly* [7,9,11]
9) anxiety (GRS9) [14]; not FDA-approved
* of questionable benefit for cognitive impairment peripheral arterial disease (data conflicting) [16]
Contraindications: Caution:
1) discontinue use prior to surgery (1-2 weeks prior)
2) avoid in patients with bleeding disorder
2) avoid in patients with seizure disorder
Dose:
1) standard extract is 24% flavonoid glycosides
a) cognitive impairment:
- 120 to 240 mg of dry leaf extract in 2-3 doses
b) peripheral arterial disease
- 120 to 1600 mg of dry leaf extract in 2-3 doses
c) prevention of cognitive decline post ischemic stroke 450 mg QD [17]
2) capsules 40 mg
3) usual dose 40 mg TID
4) range 80-240 mg/day
5) gingi fluid extract 1:1, 25% alcohol: 1-2 mL TID
6) start with low dose & titrate upward to avoid headache
7) discontinue 36 hours before surgery [12]
Pharmacokinetics:
1) at least 8 weeks of treatment for cognitive impairment
2) at least 6 weeks of treatment for peripheral vascular disease
3) Ginkgo probably induces CYP2C19
Adverse effects:
1) increase risk for bleeding
- case reports of subarachnoid hemorrhage & hyphemas
2) GI distress (common)
a) nausea
b) diarrhea
3) headache (common)
- use a low dose & titrate upward
4) no data on safety during pregnancy
5) no toxicity reported with leaf
6) skin contact with fruit can cause a poison ivy type syndrome
7) seizures (case reports); reduces seizure threshold [10]
8) anxiety [12]; used for anxiety (GRS9) [14]
Drug interactions:
1) potential interaction with anticoagulants*
a) warfarin (coumadin)
b) heparin
2) potential interactions with antiplatelet agents*
- non-steroidal anti-inflammatory agents (NSAIDs)
- SSRI (fluoxetine) [16]
3) anticonvulsive agents
4) possible interaction with drugs that lower seizure threshold [6,8]
- antipsychotics, antidepressants, cholinesterase inhibitors, decongestants, sedating antihistamines, systemic steroids, methylphenidate, fentanyl, theophylline, cyclosporine
5) tricyclic antidepressants (TCA)
6) trazodone (Desyrel) in combination may cause CNS depression by overstimulation of GABA receptors [5]
7) diminished levels of drugs metabolized by CYP2C19 [8]
- ginkgo decreases omeprazole levels & probably other proton pump inhibitors [8]
8) MAO inhibitors increase effect & toxicity of ginkgo [12]
9) possible interactions with alprazolam, buspirone, efavirenz [16]
* discontinue 36 hours before surgery [12]
Mechanism of action:
1) active ingredients:
a) Ginkgo flavone glycosides & heterosides
1] quercetin
2] kaempferol
3] isorhamnetine
b) terpenes
c) organic acids
d) the leaves are extracted with acetone:water, the organic solvent removed & the extract dried & processed
2) membrane stabilizing
3) free radical scavenger
4) enhances cellular uptake & utilization of glucose & O2
5) make enhance action of Na+/K+ ATPase
6) vasodilation via nitric oxide & prostacyclin
7) may enhance venous tone
8) inhibits platelet activation, adhesion & degranulation due to direct membrane & antioxidant effects
9) increased synthesis of prostacyclin
10) antagonist of platelet activating factor (PAF)
11) improved rheological properties of blood
11) improvement of hypoxic tolerance
Interactions
drug interactions
General
pharmaceutical herb; medicinal herb; herbal supplement; botanical
References
- Victoria Rand, UCSF Fresno Lecture, 10/7/98
- Le Bara et al, JAMA October 1997
- Kleijnen et al, British J Clinical Pharmacology, 1992
- Kaiser Permanente, Northern California Regional Pharmacy &
Therapeutics Committee
- Prescriber's Letter 7(9):53 2000
- Prescriber's Letter 9(2):9 2002
- Journal Watch 22(18):140, 2002
Prescriber's Letter 9(9):53-54 2002
Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R.
Ginkgo for memory enhancement: a randomized controlled trial.
JAMA. 2002 Aug 21;288(7):835-40.
PMID: 12186600
- Prescriber's Letter 12(9): 2005
Drug Interactions with Ginkgo
Detail-Document#: 210910
(subscription needed) http://www.prescribersletter.com
- DeKosky ST et al
Ginkgo biloba for Prevention of Dementia
JAMA. 2008;300(19):2253-2262
PMID: 19017911
- Prescriber's Letter 16(1): 2009
Ginkgo for Prevention of Dementia
Detail-Document#: 250103
(subscription needed) http://www.prescribersletter.com
- Snitz BE et al
Ginkgo biloba for Preventing Cognitive Decline in Older Adults.
JAMA. 2009;302(24):2663-2670
PMID: 20040554
http://jama.ama-assn.org/cgi/content/full/302/24/2663
- Geriatrics at your Fingertips, 13th edition, 2011
Reuben DB et al (eds)
American Geriatric Society
- Vellas B, Coley N, Ousset PJ et al
Long-term use of standardised ginkgo biloba extract for the
prevention of Alzheimer's disease (GuidAge): a randomised
placebo-controlled trial
Lancet Neurol. 2012 Oct;11(10):851-9.
PMID: 22959217
http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2812%2970206-5/abstract
- Geriatric Review Syllabus, 8th edition (GRS8)
Durso SC and Sullivan GN (eds)
American Geriatrics Society, 2013
- Geriatric Review Syllabus, 9th edition (GRS9)
Medinal-Walpole A, Pacala JT, Porter JF (eds)
American Geriatrics Society, 2016
- Hirsch C.
Ginkgo biloba extract did not reduce risk for Alzheimer disease
in elderly patients with memory complaints.
Ann Intern Med. 2013;158(2):JC7
PMID: 23318341
- Medical Knowledge Self Assessment Program (MKSAP) 17, 18
American College of Physicians, Philadelphia 2015, 2018.
- Li S, Zhang X, Fang Q et al
Ginkgo biloba extract improved cognitive and neurological
functions of acute ischaemic stroke: a randomised controlled
trial.
Stroke Vasc Neurol. 2017 Dec 18;2(4):189-197
PMID: 29507779 Free PMC Article
http://svn.bmj.com/content/early/2017/11/08/svn-2017-000104